Johnson Matthey Plc (LON:JMAT)
London
· Delayed Price · Currency is GBP · Price in GBp | Market Cap | 2.45B |
| Revenue (ttm) | 11.94B |
| Net Income (ttm) | 529.00M |
| Shares Out | 167.33M |
| EPS (ttm) | 2.89 |
| PE Ratio | 5.07 |
| Forward PE | 10.32 |
| Dividend | 0.77 (5.31%) |
| Ex-Dividend Date | Dec 5, 2024 |
| Volume | 982,402 |
| Average Volume | 550,437 |
| Open | 1,452.00 |
| Previous Close | 1,449.00 |
| Day's Range | 1,452.00 - 1,469.00 |
| 52-Week Range | 1,295.54 - 1,917.07 |
| Beta | 0.93 |
| RSI | 61.13 |
| Earnings Date | Feb 26, 2025 |
About Johnson Matthey
Johnson Matthey Plc engages in the clean air, catalyst and hydrogen technology, and platinum group metals (PGM) service businesses in the United Kingdom, Germany, rest of Europe, the United States, rest of North America, China, rest of Asia, and internationally. It operates through five segments: Clean Air, PGM Services, Catalyst Technologies, Hydrogen Technologies, and Value Businesses. The Clean Air segment provides catalysts for emission control after-treatment systems to reduce harmful emissions from cars, other light duty vehicles, trucks,... [Read more]
Financial Performance
In 2023, Johnson Matthey's revenue was 12.84 billion, a decrease of -14.00% compared to the previous year's 14.93 billion. Earnings were 108.00 million, a decrease of -60.87%.
Financial StatementsNews
UK Stock Market News: Filtronic, Likewise, Johnson Matthey
Filtronic signs new SpaceX deal, Likewise update shows strong ’24 momentum continuing, JMAT CFO to depart & new appointment already made
UK Stock Market News: Johnson Matthey, Dr Martens, Ryanair
Can Johnson Matthey placate activist investors? Q3 numbers show Dr Martens remains big in Japan, Ryanair update shows strong Christmas
Johnson Matthey to review executive pay, cut spend in hydrogen technologies
British autocatalyst maker Johnson Matthey said on Monday it would review its executive pay and cut its capital expenditure in its hydrogen technologies business to boost its cash following pressure f...
Johnson Matthey says it is making ‘progress’ after investor criticism
US investor Standard Industries had renewed demands for an overhaul of the chemical technologies firm.
Johnson Matthey investor rejects chemicals group's response to board overhaul calls
American venture capital firm Standard Investments, which has an 11 per cent stake in Johnson Matthey, wrote a letter last month urging the company to nominate new directors.
Top investor in UK industrial giant Johnson Matthey demands overhaul
The US-based investor said the British firm, one of the biggest makers of catalytic converters for car exhausts, needed a board shake-up.
Investor demands Johnson Matthey board shake-up to reverse share price slump
Standard Industries warned 'decisive action must be taken' as it also called for the sale of the firm's Hydrogen Technologies unit.
Half Year 2025 Johnson Matthey PLC Earnings Presentation Transcript
Half Year 2025 Johnson Matthey PLC Earnings Presentation Transcript
Johnson Matthey Plc (JMPLF) Q2 2025 Earnings Call Transcript
Johnson Matthey Non-GAAP EPS of 266.80p, revenue of £5.63B
Johnson Matthey Plc (JMPLF) Q4 2024 Earnings Call Transcript
Johnson Matthey Plc (OTCPK:JMPLF) Q4 2024 Earnings Conference Call May 23, 2024 4:00 AM ETCompany ParticipantsMartin Dunwoodie - Director of Investor...
Big Hitters Team Up to Produce Sustainable Aviation Fuel Out of Sugar Cane
Renewable hydrogen producer DG Fuels, energy giant BP and chemicals maker Johnson Matthey plan to produce 180 million gallons of SAF a year in Louisiana.
Johnson Matthey sells medical device components business for $700M
Johnson Matthey agrees £550m deal to sell business unit
The unit has manufacturing sites in the US, Mexico, and Australia.
Johnson Matthey signs agreement to sell its Medical Device Components business for US$700m
Johnson Matthey Plc This announcement contains inside information LONDON , March 20, 2024 /PRNewswire/ -- Johnson Matthey Plc (JM) announces that it has signed a definitive agreement to sell 100% of i...
Johnson Matthey to offload medical device parts division for £550m
The chemicals giant, which makes catalytic converters for cars, said the sale meant it had finished a programme announced in May 2022 to divest its 'value businesses.'
UK's Johnson Matthey to sell medical device business for $700 mln
Britain's Johnson Matthey (JM) will sell its medical device components business to Montagu Private Equity for $700 million in cash, as part of its strategy to focus on growth units and streamline oper...
Johnson Matthey PLC's Dividend Analysis
Johnson Matthey PLC's Dividend Analysis
Johnson Matthey Plc goes ex dividend tomorrow
Johnson Matthey Plc (JMPLY) declares $0.5344/share quarterly dividend, in line with previous. Forward yield 5.1% Payable Feb. 16; for shareholders of record Dec
Johnson Matthey to benefit from sustainable fuel push says BofA
Johnson Matthey PLC (LSE:JMAT)'s has a far better cah flow profile than its valuation indicates, according to analysts at Bank of America. The bank has upgraded the firm which was recently demoted to ...
Johnson Matthey Plc (JMPLF) Q2 2024 Earnings Call Transcript
Johnson Matthey Plc (OTCPK:JMPLF) Q2 2024 Earnings Conference Call November 22, 2023 4:00 AM ETCompany ParticipantsMartin Dunwoodie - Head, Investor...
Johnson Matthey GAAP EPS of 59.10p, revenue of £6.53B
Johnson Matthey announces 1H GAAP EPS of 59.10p. Revenue of £6.53B, a decrease of 10.9% YoY.
Johnson Matthey Plc 2024 Q2 - Results - Earnings Call Presentation
The following slide deck was published by Johnson Matthey Plc in conjunction with their 2024 Q2 earnings call.
Chemicals giant Johnson Matthey reveals plan to cut 600 more jobs
The global manufacturer also said it aims cut up to 30% of its management team.
UK's Johnson Matthey to cut 600 jobs to focus on energy-transition units
British autocatalyst maker Johnson Matthey said on Wednesday it would cut about 600 jobs in support functions, as it outsources some business processes to sharpen focus on its energy transition units.